IRVINE, CA – Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological ...

Filing details $400 million license for smart robot system and claims retail giant’s “reverse acquihire” contract limits ...

Presidency on Saturday, said Former President Muhammadu Buhari’s decision to appear in a Paris arbitration court to give ...

On January 16, the U.S. Securities and Exchange Commission (SEC) announced settled charges against New York-based investment ...

On January 13, 2025, the CFPB announced a proposed rule aimed at prohibiting companies from including in consumer agreements ...